Breakout watch: Savvy investors bet millions on royalty-fueled pharma stock
On the IBD 50 and the latest list of new buys by top funds, Ligand stock targets a breakout but faces this test first.
On the IBD 50 and the latest list of new buys by top funds, Ligand stock targets a breakout but faces this test first.